A research team from Westlake University in China has created a handheld cancer detection device that can identify early-stage lung cancer biomarkers from a single drop of blood, marking a significant advancement in cancer screening technology. The device achieved an impressive 94.9% accuracy in clinical tests involving over 170 serum samples, and it can provide results in approximately 15 minutes. Utilizing a light-based sensing technique called Q-modulated refractometric sensing, the compact device consists of only three main components: a 3D sensing chip, an LED light source, and a photodetector. This innovation could make cancer diagnostics more accessible, especially in rural areas lacking specialized medical facilities. However, experts caution that while the accuracy is promising, further validation through larger clinical trials and regulatory approvals is necessary before the device can be widely implemented in healthcare settings. The development aligns with the growing interest in non-invasive liquid biopsy technologies, which aim to identify cancer markers without invasive procedures.